Cargando…

The Blockage of KCa3.1 Channel Inhibited Proliferation, Migration and Promoted Apoptosis of Human Hepatocellular Carcinoma Cells

The intermediate conductance calcium-activated potassium channel KCa3.1 plays an important role in regulating cell proliferation and migration. However, the role of KCa3.1 channel in human hepatocellular carcinoma remained unknown. This study was therefore performed to investigate the effects of KCa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yu, Zhao, Liang, Ma, Wenya, Cao, Xuefeng, Chen, Hongyang, Feng, Dan, Liang, Jing, Yin, Kun, Jiang, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466414/ https://www.ncbi.nlm.nih.gov/pubmed/26078795 http://dx.doi.org/10.7150/jca.11913

Ejemplares similares

Contribution of the KCa3.1 channel–calmodulin interactions to the regulation of the KCa3.1 gating process
por: Morales, Patricia, et al.
Publicado: (2013)

KCa3.1 and TRPM7 Channels at the Uropod Regulate Migration of Activated Human T Cells
por: Kuras, Zerrin, et al.
Publicado: (2012)

Characterization of the PCMBS-dependent modification of KCa3.1 channel gating
por: Bailey, Mark A., et al.
Publicado: (2010)

KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo
por: D'Alessandro, G, et al.
Publicado: (2013)

KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma
por: Brown, Brandon M., et al.
Publicado: (2018)

Role of KCa3.1 Channels in Modulating Ca(2+) Oscillations during Glioblastoma Cell Migration and Invasion
por: Catacuzzeno, Luigi, et al.
Publicado: (2018)

KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment
por: D'Alessandro, Giuseppina, et al.
Publicado: (2016)

Novel Phenolic Inhibitors of Small/Intermediate-Conductance Ca(2+)-Activated K(+) Channels, KCa3.1 and KCa2.3
por: Oliván-Viguera, Aida, et al.
Publicado: (2013)

Effects of KCa channels on biological behavior of trophoblasts
por: Zhang, Xiaolei, et al.
Publicado: (2022)

Microglial KCa3.1 Channels as a Potential Therapeutic Target for Alzheimer's Disease
por: Maezawa, Izumi, et al.
Publicado: (2012)

Histidine phosphorylation relieves copper inhibition in the mammalian potassium channel KCa3.1
por: Srivastava, Shekhar, et al.
Publicado: (2016)

The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury
por: Sevelsted Møller, Linda, et al.
Publicado: (2016)

KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis
por: Anumanthan, Govindaraj, et al.
Publicado: (2018)

Involvement of KCa3.1 channel activity in immediate perioperative cognitive and neuroinflammatory outcomes
por: Saxena, Sarah, et al.
Publicado: (2023)

Modulation of Retrograde Trafficking of KCa3.1 in a Polarized Epithelium
por: Lee, Bob Shih-Liang, et al.
Publicado: (2017)

Functional KCa1.1 channels are crucial for regulating the proliferation, migration and differentiation of human primary skeletal myoblasts
por: Tajhya, Rajeev B, et al.
Publicado: (2016)

Expression and Role of the Intermediate-Conductance Calcium-Activated Potassium Channel KCa3.1 in Glioblastoma
por: Catacuzzeno, Luigi, et al.
Publicado: (2012)

Crystal structure of the C-terminal four-helix bundle of the potassium channel KCa3.1
por: Ji, Tianyang, et al.
Publicado: (2018)

Functional Roles of the Ca(2+)-activated K(+) Channel, KCa3.1, in Brain Tumors
por: D’Alessandro, Giuseppina, et al.
Publicado: (2018)

Functional cooperation between KCa3.1 and TRPC1 channels in human breast cancer: Role in cell proliferation and patient prognosis
por: Faouzi, Malika, et al.
Publicado: (2016)

Functional Cooperation between KCa3.1 and TRPV4 Channels in Bronchial Smooth Muscle Cell Proliferation Associated with Chronic Asthma
por: Yu, Zhihua, et al.
Publicado: (2017)

Complementary roles of KCa3.1 channels and β1-integrin during alveolar epithelial repair
por: Girault, Alban, et al.
Publicado: (2015)

The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke
por: Yi, Mengni, et al.
Publicado: (2017)

Correction: Crystal structure of the C-terminal four-helix bundle of the potassium channel KCa3.1
por: Ji, Tianyang, et al.
Publicado: (2018)

Investigating CFTR and KCa3.1 Protein/Protein Interactions
por: Klein, Hélène, et al.
Publicado: (2016)

Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
por: Jin, Lee‐Way, et al.
Publicado: (2019)

KCa3.1 Mediates Dysregulation of Mitochondrial Quality Control in Diabetic Kidney Disease
por: Huang, Chunling, et al.
Publicado: (2021)

Increased Levels of ER Stress and Apoptosis in a Sheep Model for Pulmonary Fibrosis Are Alleviated by In Vivo Blockade of the KCa3.1 Ion Channel
por: Perera, Udari E., et al.
Publicado: (2021)

The Long Non-Coding RNA-14327.1 Promotes Migration and Invasion Potential of Endometrial Carcinoma Cells by Stabilizing the Potassium Channel Kca3.1
por: Zhang, Yingli, et al.
Publicado: (2019)

High Glucose Induces CCL20 in Proximal Tubular Cells via Activation of the KCa3.1 Channel
por: Huang, Chunling, et al.
Publicado: (2014)

The Inhibition of KCa3.1 Channels Activity Reduces Cell Motility in Glioblastoma Derived Cancer Stem Cells
por: Ruggieri, Paola, et al.
Publicado: (2012)

Radiation Increases Functional KCa3.1 Expression and Invasiveness in Glioblastoma
por: D’Alessandro, Giuseppina, et al.
Publicado: (2019)

KCa3.1 Impairment Is Not Just a Slow Afterthought in Epilepsy
por: Gross, Christina
Publicado: (2020)

miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma
por: Chen, Yaobing, et al.
Publicado: (2016)

Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes
por: Koshy, Shyny, et al.
Publicado: (2013)

The Ca(2+)-Activated K(+) Channel KCa3.1 as a Potential New Target for the Prevention of Allograft Vasculopathy
por: Chen, Yi-Je, et al.
Publicado: (2013)

Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease
por: Paka, Latha, et al.
Publicado: (2017)

The intermediate‐conductance calcium‐activated potassium channel KCa3.1 contributes to alkalinization‐induced vascular calcification in vitro
por: Bai, Yaling, et al.
Publicado: (2021)

KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis
por: Huang, Chunling, et al.
Publicado: (2014)

KCa3.1 inhibition switches the phenotype of glioma-infiltrating microglia/macrophages
por: Grimaldi, A, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t1ormb25gvffmmspim8n4prlfl